# A Study of Ralinepag in Healthy Chinese Adult Subjects

> **NCT04613999** · PHASE1 · COMPLETED · sponsor: **Everstar Medicines (Shanghai) Limited** · enrollment: 15 (actual)

## Conditions studied

- Healthy Volunteer
- Pharmacokinetic Study

## Interventions

- **DRUG:** Ralinepag

## Key facts

- **NCT ID:** NCT04613999
- **Lead sponsor:** Everstar Medicines (Shanghai) Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-09
- **Primary completion:** 2020-11-09
- **Final completion:** 2020-11-09
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2024-02-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04613999

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04613999, "A Study of Ralinepag in Healthy Chinese Adult Subjects". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04613999. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*